118 related articles for article (PubMed ID: 12355955)
1. [Every-other-day TS-1 administration for recurrent or non-curative advanced gastric carcinoma].
Arai W; Hosoya Y; Hyodo M; Yokoyama T; Saito S; Kurasina K; Aoki T; Yasuda Y; Nagai H; Tamada K
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1651-5. PubMed ID: 12355955
[TBL] [Abstract][Full Text] [Related]
2. [A case of type 4 gastric cancer with peritoneal dissemination successfully treated over 2 years by alternate-day administration of TS-1].
Arai W; Hosoya Y; Yokoyama T; Saito S; Hirashima Y; Hyodo M; Yasuda Y; Nagai H; Shirasaka T
Gan To Kagaku Ryoho; 2004 Feb; 31(2):237-40. PubMed ID: 14997759
[TBL] [Abstract][Full Text] [Related]
3. [A case of advanced gastric cancer with bone metastases and DIC responding to oral administration of TS-1].
Omatsu T; Ichikawa H; Kawahito Y; Ashihara E; Yamamoto A; Kadoya M; Takegami T; Takanashi Y; Naito Y; Yoshida N; Sugino S; Yoshikawa T
Gan To Kagaku Ryoho; 2003 Jun; 30(6):869-73. PubMed ID: 12852359
[TBL] [Abstract][Full Text] [Related]
4. Alternate-day oral therapy with TS-1 for advanced gastric cancer.
Arai W; Hosoya Y; Hyodo M; Yokoyama T; Hirashima Y; Yasuda Y; Nagai H; Shirasaka T
Int J Clin Oncol; 2004 Jun; 9(3):143-8. PubMed ID: 15221596
[TBL] [Abstract][Full Text] [Related]
5. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
[TBL] [Abstract][Full Text] [Related]
6. [A new therapeutic approach to advanced and recurrent gastric cancer by TS-1].
Yoshida K; Nishimoto N; Kagawa Y; Hihara J; Inoue H; Kim R; Hirai T; Nishiyama M; Toge T
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1403-12. PubMed ID: 11681248
[TBL] [Abstract][Full Text] [Related]
7. [Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1].
Suzuki T; Iwabuchi M; Matsuda Y; Imai G; Yokoyama H; Mochida A; Takahashi H; Shiina M; Yamada K; Ishibashi J; Suzuki S; Chida N; Tadokoro K
Gan To Kagaku Ryoho; 2003 Jan; 30(1):133-9. PubMed ID: 12557719
[TBL] [Abstract][Full Text] [Related]
8. [Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1].
Hiramatsu K; Mizukami Y; Momiyama M; Suzuki M; Niimi K; Nagashima T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1163-6. PubMed ID: 16121921
[TBL] [Abstract][Full Text] [Related]
9. [An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1].
Shibata N; Eto TA; Hotokezaka M; Iwamura T; Chijiiwa K
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1159-62. PubMed ID: 16121920
[TBL] [Abstract][Full Text] [Related]
10. [A case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1].
Koyama M; Inaba Y; Watabe S; Hayashi K; Tsuge T; Kamio Y; Chiba M; Tamura M
Gan To Kagaku Ryoho; 2003 Apr; 30(4):531-5. PubMed ID: 12722688
[TBL] [Abstract][Full Text] [Related]
11. [TS-1 treatment for progressive gastric cancer in a patient on chronic dialysis--assessment of dosage regimen by monitoring blood concentrations of therapeutic drugs (TDM)].
Tanaka T; Fujita S; Tanaka N; Ooka M; Okajima S; Tanaka N
Gan To Kagaku Ryoho; 2005 Jun; 32(6):841-5. PubMed ID: 15984528
[TBL] [Abstract][Full Text] [Related]
12. [Remnant gastric cancer in which prolonged no change status was maintained with low-dose TS-1--a case report].
Takemura M; Osugi H; Lee S; Taguchi S; Kaneko M; Tanaka Y; Fukuhara K; Fujiwara Y; Nishizawa S; Kinoshita H
Gan To Kagaku Ryoho; 2003 May; 30(5):695-8. PubMed ID: 12795104
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of pre-operative administration of TS-1 in patients with advanced gastric or colorectal cancer--estimation of pathological effectiveness for postoperative adjuvant chemotherapy with TS-1].
Nakano K; Koizumi H; Okugawa K; Nakamura K; Osaka Y; Tsuchiya K; Sako H; Tanabe S; Nakane Y
Gan To Kagaku Ryoho; 2005 Mar; 32(3):329-33. PubMed ID: 15791815
[TBL] [Abstract][Full Text] [Related]
14. [Case report: a recurrent gastric cancer in the terminal stage, associated with obstructive jaundice which responded significantly to oral administration of TS-1].
Tasaka K; Tomofuzi Y; Sugihara Z; Fukuda H
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1445-8. PubMed ID: 11681255
[TBL] [Abstract][Full Text] [Related]
15. [A case of CA19-9 producing gastric cancer treated by low-dose administration of TS-1 for adjuvant chemotherapy].
Takashima I; Seto Y; Nagamine I; Kegoya Y; Kodoi A; Nakayama H
Gan To Kagaku Ryoho; 2005 Apr; 32(4):503-5. PubMed ID: 15853217
[TBL] [Abstract][Full Text] [Related]
16. [Postoperative chemotherapy with a novel oral anticancer drug composed of tegafur, gimeracil and oteracil potassium to curability C scirrhus type gastric cancer].
Iwatani Y; Shimada Y; Ohshima T; Kusunoki N; Yamazaki T; Miyazaki N
Gan To Kagaku Ryoho; 2001 Aug; 28(8):1129-32. PubMed ID: 11525030
[TBL] [Abstract][Full Text] [Related]
17. [Three cases of advanced and recurrent gastric cancer treated with paclitaxel after TS-1 administration].
Fujiwara Y; Tamura S; Yoshioka S; Okada Y; Takiguchi S; Yano M; Yasuda T; Monden M
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2555-9. PubMed ID: 12506482
[TBL] [Abstract][Full Text] [Related]
18. [A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy].
Yamada K; Sugiyama Y; Seino K; Kobori H; Ebina T; Shibata S; Kawasaki H; Sasaki M; Tanaka M
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1447-51. PubMed ID: 16227746
[TBL] [Abstract][Full Text] [Related]
19. [Low-dose paclitaxel therapy as second-line chemotherapy for patients who previously received TS-1 therapy].
Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2183-6. PubMed ID: 15628768
[TBL] [Abstract][Full Text] [Related]
20. [A new regimen for TS-1 therapy designed to minimize adverse reactions by introducing a one-week interval after each two-week dosing session].
Kimura Y; Kikkawa N; Iijima S; Kato T; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1403-9. PubMed ID: 12214468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]